Mutations in the PLCG2 gene, which encodes an enzyme in the intracellular signaling pathway of B lymphocytes, result in a spectrum of conditions involving frequent infections, antibody deficiencies, immune dysregulation, and cutaneous manifestations. Here, PLCG2 is linked to agammaglobulinemia.